1. Introduction {#sec1-genes-10-00988}
===============

Gestational diabetes mellitus (GDM) is one of the common complications in pregnancy. Its prevalence in Asia is 11.5% \[[@B1-genes-10-00988]\]. GDM is a known risk factor for neonatal adverse outcomes \[[@B2-genes-10-00988],[@B3-genes-10-00988],[@B4-genes-10-00988]\]. Additionally, a diagnosis of GDM is a stressful life event \[[@B5-genes-10-00988],[@B6-genes-10-00988],[@B7-genes-10-00988],[@B8-genes-10-00988]\] which has an adverse impact on self-perception towards health and quality of life \[[@B6-genes-10-00988],[@B9-genes-10-00988]\]; as well as increased odds of experiencing emotional distress. Previous studies reported that the prevalence of depression among women sufferers from GDM stood at 56.7%, while anxiety was 57.7%, and stress was even higher at 62.8% \[[@B10-genes-10-00988],[@B11-genes-10-00988],[@B12-genes-10-00988]\]. GDM and perinatal mental problems undeniably affect all members of the family \[[@B13-genes-10-00988]\]. This mental condition may reoccur or worsen to postpartum depression \[[@B14-genes-10-00988]\]. Multiple determinants such as socio-demographical background, maternal and clinical profiles have a reported positive association with psychological symptoms \[[@B15-genes-10-00988],[@B16-genes-10-00988],[@B17-genes-10-00988],[@B18-genes-10-00988],[@B19-genes-10-00988]\].

Genetic factors clearly play a substantial role in the etiology of psychological symptoms of depression, anxiety and/or stress, as evidenced by other studies, which indicate a heritability ranges from 45% to 50% for these disorders \[[@B20-genes-10-00988],[@B21-genes-10-00988],[@B22-genes-10-00988]\]. The genetic profile of the mother is particularly important if she wants to determine whether her child will be predispose to psychological disorders in the future. However, it is challenging to identify particular genetic variants underlying for symptoms of depression, anxiety and/or stress susceptibility because their psychological symptoms are not caused by single gene, but a complex interaction among multiple genes, socio-demographic background, clinical, and biological moderators \[[@B23-genes-10-00988]\]. The candidate gene-by-environment interaction hypothesis regarding psychological symptoms of depression, anxiety and/or stress has received widespread attention and acclaim; therefore, many studies to date have used this approach to underpin their findings for genetic effects on psychological symptoms of depression, anxiety, and/or stress \[[@B24-genes-10-00988]\].

Indeed, it is not difficult to find studies which have reported a significant association between candidate genes and these psychological symptoms, such as brain-derived neurotrophic factor (*BDNF*) \[[@B25-genes-10-00988],[@B26-genes-10-00988]\] and oxytocin receptor genes (*OXTR*) \[[@B27-genes-10-00988],[@B28-genes-10-00988]\]. These genes may be associated with depression or anxiety; however, there are ample studies which have failed to replicate the same results in the candidate gene literature \[[@B29-genes-10-00988],[@B30-genes-10-00988],[@B31-genes-10-00988]\]. One explanation for this lack of success in producing the replicable main effect of these genes is that the certain genetic variants are highly dependent on the gender, population, and disease-related outcomes \[[@B32-genes-10-00988]\]; even though these studies have recruited patients with major depressive disorder \[[@B27-genes-10-00988],[@B28-genes-10-00988],[@B29-genes-10-00988],[@B30-genes-10-00988],[@B31-genes-10-00988],[@B32-genes-10-00988],[@B33-genes-10-00988],[@B34-genes-10-00988],[@B35-genes-10-00988],[@B36-genes-10-00988],[@B37-genes-10-00988],[@B38-genes-10-00988],[@B39-genes-10-00988],[@B40-genes-10-00988],[@B41-genes-10-00988]\]; anxiety disorder \[[@B42-genes-10-00988],[@B43-genes-10-00988],[@B44-genes-10-00988]\]; and post-traumatic stress disorders \[[@B45-genes-10-00988]\] diagnosed according to Diagnostic and Statistical Manual of Mental Disorders and/or International Statistical Classification of Diseases. This has led to increasing skepticism about the true association or lack thereof between candidate genes and psychological symptoms of depression, anxiety and/or stress. Without testing the candidate genes in our population, it is difficult to conclude that the previous results are also applicable in our samples. One strategy that may aid in identifying the candidate genes in association with symptoms of depression, anxiety and/or stress is to interrogate several candidate genes thought to be associated with the underlying psychological symptoms of depression, anxiety and/or stress. To this end, we have constructed a custom of SNP array containing 18 genes that were chosen based on hypotheses regarding biological systems of relevance to depression \[[@B46-genes-10-00988],[@B47-genes-10-00988],[@B48-genes-10-00988],[@B49-genes-10-00988],[@B50-genes-10-00988]\]; anxiety \[[@B42-genes-10-00988],[@B51-genes-10-00988],[@B52-genes-10-00988]\] and stress \[[@B45-genes-10-00988],[@B53-genes-10-00988]\]. These custom SNPs provide excellent coverage of many previously suggested and functionally important candidate genes for depression, anxiety and stress, including *NPY5R* \[[@B42-genes-10-00988],[@B52-genes-10-00988]\]; *ANO2* \[[@B42-genes-10-00988]\]; *EPHX2* \[[@B42-genes-10-00988],[@B51-genes-10-00988]\]; *TPH2* \[[@B35-genes-10-00988]\]; *NRG1* \[[@B34-genes-10-00988]\]; *LHPP* \[[@B38-genes-10-00988],[@B39-genes-10-00988],[@B54-genes-10-00988]\]; *FKBP5* \[[@B41-genes-10-00988],[@B45-genes-10-00988]\]; *SDK2* \[[@B42-genes-10-00988]\]; *RORA* \[[@B33-genes-10-00988],[@B55-genes-10-00988]\]; *OXTR* \[[@B27-genes-10-00988],[@B28-genes-10-00988]\]; *BDNF* \[[@B56-genes-10-00988],[@B57-genes-10-00988]\]; *HTR2C* \[[@B43-genes-10-00988]\]; *TEX51* \[[@B42-genes-10-00988]\]; and *PLEKHG1* \[[@B42-genes-10-00988]\]. Many of the genes represented on the array have also been reported to be involved in associated heritable phenotypes that are associated with symptoms of depression, anxiety and/or stress. Despite that, the putative susceptibility genes for depression, anxiety or stress have yet to be definitively identified among GDM women.

In light of the complications caused by GDM itself and the devastating consequences of depression and related psychological symptoms of anxiety and stress among women with GDM, we suggest performing a study of fourteen candidate genes to elucidate its genotypic effect on symptoms of depression, anxiety and/or stress among GDM women. The aim of the present study was to perform candidate gene analysis via mass array to evaluate the associations, if any, between phenotypes of threes psychological symptoms and fourteen candidate genes, as adjusted for socio-demographical background, maternal and clinical profile among GDM women.

2. Materials and Methods {#sec2-genes-10-00988}
========================

2.1. Study Population {#sec2dot1-genes-10-00988}
---------------------

We performed a post-hoc exploratory sub-analysis of a cross-sectional study among GDM women (n = 343) to check which candidate SNPs may be associated with symptoms of depression, anxiety and/or stress in this particular population. We conducted a genetic association study using the cross-sectional study from the previously described "Prevalence and factors associated with depressive, anxiety and stress symptoms among women with gestational diabetes mellitus in tertiary care centres: A cross-sectional study", which was conducted between July 2018 and October 2018 in Malaysia \[[@B58-genes-10-00988]\]. The study participants were women enrolled in second or third trimester care and diagnosed with GDM at Hospital Kuala Lumpur or Hospital Serdang. All participants were native Malaysians and residents of surrounding areas. The detailed study protocol has been described previously \[[@B58-genes-10-00988]\]. In that study, 526 women agreed to participate. Upon completion of sample collection and analysis, data for depression, anxiety and stress score and polymorphisms of candidate genes were available for a total of 343 participants.

The general inclusion criteria were that the pregnant women were Malaysian, aged ≥18 years old, with a diagnosis of GDM. The diagnosis of GDM is defined as fasting plasma glucose ≥5.1 mmol/L or 75 g two-hours oral glucose tolerance test ≥ 7.8 mmol/L according to Malaysian Clinical Practice Guidelines \[[@B59-genes-10-00988],[@B60-genes-10-00988]\]. The exclusion criteria were those with pre-existing diabetes.

Regarding patients and controls, patients with depression were defined as those with the DASS depression subscale score ≥10; otherwise, they were in control group if scoring \<10 in the DASS-depression subscale. Similarly, they were categorized as a patient for anxiety if they scored ≥8 in the DASS anxiety subscale; they were in control group if the score was \<8. They were categorized as a patient for stress if they scored ≥15 in the DASS stress subscale, and placed in the control group if scoring \<15 in the DASS stress subscale.

2.2. Socio-Demographic Background and Clinical Characteristics {#sec2dot2-genes-10-00988}
--------------------------------------------------------------

Socio-demographic backgrounds and clinical characteristics were recorded at enrollment to obtain information related to maternal profile, past-obstetrics history, concurrent medical problems, and family history. These data were obtained from the self-administered questionnaire and medical records.

2.3. Measurement of Depression, Anxiety and Stress Symptoms {#sec2dot3-genes-10-00988}
-----------------------------------------------------------

The detailed sampling and assessment of depression, anxiety, and stress symptoms have been previously described \[[@B58-genes-10-00988]\]. We used an English \[[@B61-genes-10-00988]\] and Malay \[[@B62-genes-10-00988]\] version of the validated questionnaire on Depression, Anxiety, and Stress-21 items (DASS-21). DASS-21 is a valid and reliable measure to screen for depression, anxiety, and stress symptoms among both non-clinical and clinical populations. The English version of the questionnaire (DASS-21) has strong validation, with Cronbach's alpha values of 0.72 for depression; 0.77 for anxiety; and 0.70 for stress, and the overall Cronbach's alpha for DASS-21 is 0.88 \[[@B61-genes-10-00988]\]. The translated Malay version of the DASS-21 questionnaire has good Cronbach's alpha values, as well as among the Malaysian population (0.84 for depression; 0.74 for anxiety; and 0.79 for stress) \[[@B62-genes-10-00988]\] and among diabetic patients (0.75 for depression; 0.74 for anxiety; and 0.79 for stress) \[[@B63-genes-10-00988]\]. The participants rated on a 4-point severity scale their experiences over the preceding week. Scores for subscale for depression, anxiety, and stress were calculated. The depression symptoms defined to follow the depression subscale, ≥10; anxiety symptoms, ≥8; and stress symptoms, ≥15 \[[@B61-genes-10-00988]\].

2.4. Blood Sample Collection and DNA Extraction {#sec2dot4-genes-10-00988}
-----------------------------------------------

Samples of 5 mL of blood were collected from the participants' peripheral blood using a 21-gauge needle with a 5.0 mL syringe by a qualified phlebotomist into EDTA tubes (Becton Dickinson, East Rutherford, NJ, USA). The samples were kept in portable icebox at 4 °C during the transportation and there were stored at −20 °C in laboratory for further analysis. Genomic DNA was isolated by using the QIAamp Blood DNA Mini Kit (QIAGEN, Hilden, Germany). The quantity and purity of extracted DNA were checked using a Biophotometer (Eppendorf, Hamburg, Germany). First, readings of a blank using distilled water against A260 and A280 of the genomic DNA were obtained. The DNA absorbed UV light with a maximum absorbance of 260 nm, while the protein absorbed UV light with a maximum absorbance of 280 nm. By dividing the amount of UV absorption at 260 nm by the absorption at 280 nm, the standard measure of the purity of the genomic DNA could be calculated. The genomic DNA was measured to be relatively free of protein impurity when the ratio of optical density was between 1.7 and 2.0.

2.5. Mass Array Genotyping {#sec2dot5-genes-10-00988}
--------------------------

Genes candidates were selected based on previous data implicating an association with the studies SNPs and clinical syndrome of depression \[[@B27-genes-10-00988],[@B28-genes-10-00988],[@B29-genes-10-00988],[@B30-genes-10-00988],[@B31-genes-10-00988],[@B32-genes-10-00988],[@B33-genes-10-00988],[@B34-genes-10-00988],[@B35-genes-10-00988],[@B36-genes-10-00988],[@B37-genes-10-00988],[@B38-genes-10-00988],[@B39-genes-10-00988],[@B40-genes-10-00988],[@B41-genes-10-00988]\]; anxiety \[[@B42-genes-10-00988],[@B43-genes-10-00988],[@B44-genes-10-00988]\] or stress \[[@B45-genes-10-00988]\] diagnosed according to Diagnostic and Statistical Manual of Mental Disorders and/or International Statistical Classification of Diseases. The genotyping analysis of candidate genes polymorphism was analyzed using Agene^®^ MassARRAY platform. SNP analysis was analyzed by Typer Analyzer. Details of candidate genes (location and sequence of SNP) were shown in [Table A1](#genes-10-00988-t0A1){ref-type="table"}.

2.6. Statistical Analysis {#sec2dot6-genes-10-00988}
-------------------------

We used IBM SPSS Statistics version 21.0 to perform the data analysis. A chi-square goodness-of-fit test was performed to assess the agreement of the genotype distribution among candidate genes using Hardy--Weinberg equilibrium, if the *p-*value for chi-square goodness-of-fit tests is significant (*p* \< 0.05), the population is not in Hardy--Weinberg equilibrium. If the genotype distribution of candidate genes is not fit to Hardy--Weinberg equilibrium based on equal distribution, expected values for genotype distribution will be adjusted according to the global population. Univariate analysis was used to analyze the association between candidate genes and the presence of depression, anxiety, or stress symptoms among GDM women. The significant difference was set to *p*-value \< 0.05. In addition, we tested the candidate gene polymorphism associations with depression phenotypes and any polymorphism adjusted for socio-demographical and clinical moderator effects. Variables with a *p*-value of less than 0.25 in univariate analysis underwent multiple logistic regression \[[@B64-genes-10-00988]\], because a *p*-value set at \<0.05 may miss any variables known to be important \[[@B65-genes-10-00988],[@B66-genes-10-00988]\]. A backward stepwise regression method was used \[[@B67-genes-10-00988]\]. All analyses were made with a 95% CI, and the level of significance was set at *p*  \< 0.05.

2.7. Ethical Consideration {#sec2dot7-genes-10-00988}
--------------------------

The study was conducted after written informed consent was obtained from all participants. The Medical Research Ethics Committee (MREC), Ministry of Health Malaysia approved the study protocol (NMRR-17-2264-37814).

3. Results {#sec3-genes-10-00988}
==========

Overall, we found that almost 50% of women with GDM suffered from anxiety symptoms, which was notably higher than symptoms of either depression (13.4%) or stress (11.7%). We also found a significant association between a specific SNP of gene *EPHX2* and depression, as well as SNPs of *EPHX2*, *OXTR*, *NRG1* with stress symptoms.

Analyses of the socio-demographic background and clinical characteristics of the final 343 participants were stratified by psychological problem, as shown in [Table 1](#genes-10-00988-t001){ref-type="table"}. Among the various backgrounds and clinical characteristics evaluated, significant differences were observed only in terms of self-monitoring with a glucometer, ethnicity, religion, marital status, underlying with allergy and family history of depression and anxiety (*p* \< 0.05) in between those with and without depression symptoms. After a Bonferroni adjustment in the context of family-wise error, these variables (ethnicity, religion, marital status, underlying with allergy and family history of depression and anxiety) still had an adjusted *p*-value \< 0.05, except self-monitoring with glucometer (*p*-value = 0.08). Likewise, there were significant differences among ethnicity, religion, smoking habit, and underlying asthma among those with and without anxiety symptoms (*p* \< 0.05). After a Bonferroni adjustment in the context of family-wise error for anxiety symptoms among GDM women, variables with adjusted *p*-value \< 0.05 included ethnicity and smoking habit, while adjust *p*-value for religion was 0.066 and underlying asthma (*p*-value = 0.058). Further, significant differences were observed in terms of religion, past history of GDM and underlying allergy among those with and without stress symptoms (*p* \< 0.05). After a Bonferroni adjustment in the context of family-wise error for stress symptoms among GDM women, the adjusted *p*-value for religion was 0.073, with past history of GDM (*p*-value = 0.048) and underlying allergy history (*p*-value \< 0.0001). Bonferroni correction was used to reduce risk of multiple testing error. Even though some of the variables (self-monitoring with glucometer in depression, religion, and underlying asthma in anxiety symptoms) showed significant results with *p*-values \< 0.05 after Bonferroni correction, we still proceeded with multiple logistic regression as we did not want to miss any variables known to be important as one of the predictors in our study.

The distribution of candidate gene genotypes satisfied the Hardy--Weinberg equilibrium (*p* \> 0.05) ([Table A2](#genes-10-00988-t0A2){ref-type="table"}). Analyses of the genotypes in SNPs of genes *EPHX2, NPY5R, ANO2, NRG1, FKBP5, RORA, OXTR* and *BDNF* among women with GDM were stratified by psychological symptoms and for candidate genotypes with *p*-value \> 0.25 using univariate analysis is shown in [Table 2](#genes-10-00988-t002){ref-type="table"}. The analyses of the genotypes in SNPs of genes *LHPP, SDK2, HTR2C, TEX51, PLEKHG1* and *TPH2* genotype among women with GDM stratified by presence of psychological symptoms with *p*-value \> 0.25 using univariate analysis are shown in ([Table A3](#genes-10-00988-t0A3){ref-type="table"}).

Notably, the proportion of the TT or TC genotypes was higher than that of the CC genotype in SNP of *NRG1* (T \> C in rs17466684) among GDM women with stress symptoms (13.2% versus 2.2%; *p* = 0.031). Similarly, the proportion of the TT genotype was higher compared with TG or GG genotypes in the SNP of *FKBP5* (T \> G in rs3800373) among GDM women with stress symptoms (57.5% versus 42.5%; *p* = 0.047) as shown in [Table 2](#genes-10-00988-t002){ref-type="table"}. On the other hand, there was no significant association between SNPS for candidate genes: \[*EPHX2, NPY5R, ANO2, FKBP5* (rs947008), *RORA*, *OXTR* and *BDNF*\] and stress symptoms (*p* \> 0.05). There was also no association between candidate genes and depression or anxiety symptoms (*p* \> 0.05).

The association between specific SNPs' genotype of candidate genes and psychological symptoms of depression, anxiety and/or stress adjusted for socio-demographical and clinical moderators is shown in [Table 3](#genes-10-00988-t003){ref-type="table"}. GDM women with the AA genotype in specific SNP of *EPHX2* (G \> A in rs17466684) are 7.9 times more likely to suffer from depression symptoms compared to those who carry G allele in the SNP, when adjusted for ethnicity, religion, practice of home glucose monitoring, planned pregnancy, marital status, past obstetric history of abortion, underlying with allergy, a family history of depression and anxiety and GDM. Likewise, GDM women with the AA genotype in specific SNP of *EPHX2* (G \> A in rs17466684) is at 7.7 times odds more likely of getting stress symptoms compared to those who carry G allele in the SNP adjusted for ethnicity, religion, marital status, treatment regimens, past obstetric history of GDM, underlying with allergy and asthma and a family history of depression and anxiety. Not only that, we also found that GDM women with the either AA or AG genotypes in specific SNP of *OXTR* (A \> G in rs53576) are 3.0 times more likely to suffer from stress symptoms compared to those who carry GG genotype in the SNP, as well as to those who carry either TT or TC genotypes in SNP of *NRG1* (T \> C in rs2919375), is at 9.9 times odds to experience stress symptoms compared to those who carry CC genotype in the SNP.

After a Bonferroni adjustment in the context of family-wise error for depression symptoms among GDM women, the adjusted *p*-value for self-monitoring with glucometer was 0.083, ethnicity (*p*-value = 0.003), religion (*p*-value = 0.004), marital status (*p*-value = 0.012), allergy history (*p*-value = 0.031) and family history of depression and/or anxiety (*p*-value = 0.002).

After a Bonferroni adjustment in the context of family-wise error for anxiety symptoms among GDM women, the adjusted *p*-value for ethnicity with was 0.004, religion (*p*-value = 0.066), smoking habit (*p*-value = 0.007), and asthma (*p*-value = 0.058).

After a Bonferroni adjustment in the context of family-wise error for stress symptoms among GDM women, the adjusted *p*-value for religion was 0.073, history of GDM (*p*-value = 0.048), and allergy (*p*-value \< 0.0001).

After a Bonferroni adjustment in the context of family-wise error for stress symptoms among GDM women, the adjusted *p*-value for *NRG1* (rs2919375) was 0.066.

4. Discussions {#sec4-genes-10-00988}
==============

Over the years, an increasing number of polymorphisms in candidate genes related to the psychological problems have been discovered. Even so, most candidate gene association studies have been either overpowered or underpowered to detect the odds of genotypic heterogeneity for psychological symptoms. In this study, we performed simple logistic regression for every candidate gene, followed by multiple logistic regressions to elucidate the actual effect size of genotypes on the presence of depression, anxiety and/or stress symptoms. To our knowledge, this is the first study to examine the symptoms of depression, anxiety and/or stress among GDM women in Malaysia, and is also the first study to use the gene-environmental interaction hypothesis.

It is noteworthy that anxiety symptoms were the most commonly reported symptoms among the population of pregnant women with GDM (57.4% vs. 42.6%), whereas depressive symptoms (86.6% vs. 13.4%) and stress (88.3% vs. 11.7%) were much lower.

Based on logistic regression in this study, we reported that there is significant between SNP (rs17466684) of Epoxide Hydrolase 2 gene (*EPHX2*) with depression symptoms (AOR = 7.854, 95% CI = 1.330--46.360) and stress symptoms (AOR = 7.664, 95% CI = 1.579--37.197). This is different finding compared with a study done in Japan where the carrier of AA genotype in SNP (rs17466684) of *EPHX2* was found to be a risk variant of anxiety particularly panic disorder \[[@B42-genes-10-00988],[@B68-genes-10-00988]\]. However, according to our genotypic analysis, this candidate gene was not associated with anxiety symptoms among Malaysian women. Polymorphism in *EPHX2* contributes to the odds of suffering from depression, anxiety, and stress symptoms in the Japanese and Malaysian population. A possible explanation for these findings is that *EPHX2* encodes for a key gat-keeper enzyme (soluble epoxide hydrolase) which functions in the catabolism of epoxy-fatty acids to their corresponding diols \[[@B69-genes-10-00988],[@B70-genes-10-00988],[@B71-genes-10-00988]\]. Soluble epoxide hydrolase is localized in neurons of central amygdala and this enzyme plays a vital role in neuronal firing \[[@B72-genes-10-00988]\] and it is hence believed that polymorphism in *EPHX2* reduce the potency of anti-inflammatory activity of epoxy-fatty acids in brain \[[@B73-genes-10-00988]\], thus affecting the release of functional neurotransmitters that influence neuropsychiatric disorders \[[@B74-genes-10-00988]\].

Neuregulin 1 (*NRG1*) is an important gene signaling numerous neurodevelopment processes such as neurotransmitter receptor expression regulation and synaptic plasticity \[[@B75-genes-10-00988]\]. In our study, there was a significant association between SNP (rs2919375) of *NRG1* and stress symptoms (AOR = 9.894, 95% CI = 1.159--84.427). To date, the C allele in SNP of *NRG1* (T \> C in rs2919375) is a minor allele and also a risk allele for major depression disorder among the Han Chinese population \[[@B34-genes-10-00988]\] was not found in our study. The reason for this difference is unknown. Apart from the population factor, the possible reason might be due to minor allele frequency in this study was 0.366, compared to 0.410 among Han Chinese population \[[@B34-genes-10-00988]\], therefore the effect of risk allele or genotype might be underestimated in our study. The minor allele frequency has influent on the power to detect genetic effects, SNPs with minor allele frequency ranges from 25% to 50% might give a false-positive rate ranging from 69.2% to 70.8% \[[@B76-genes-10-00988]\]. Therefore, the analysis for genes *NRG1* (T \> C in rs2919375) indicates that either TT or TC genotypes are determinants for stress symptoms, which might inflate false positive concerns.

Oxytocin receptor genes (*OXTR*) were found to have an association with neuropsychiatry disorders \[[@B27-genes-10-00988],[@B28-genes-10-00988]\]; a possible explanation is that *OXTR* regulates the expression of OXTR p53, a potent transcription factor for the oxytocinergic pathway in neurons \[[@B77-genes-10-00988],[@B78-genes-10-00988],[@B79-genes-10-00988]\]. Emerging evidence also shows that *OXTR* rs53576 was associated with the structural coupling of the hypothalamus and amygdala, alteration to this structure is potentially to inflict neuropsychiatric disorders \[[@B80-genes-10-00988],[@B81-genes-10-00988],[@B82-genes-10-00988]\]. In our study, we found a positive association between *OXTR* rs53576 and stress symptoms among GDM women. Our finding contradicts with previous studies among the Japanese population \[[@B27-genes-10-00988]\] and Caucasian in Italy \[[@B28-genes-10-00988]\]. In a Japanese study, the G allele is the minor allele and presence of either AA or AG genotypes in SNP rs53576 were associated with panic disorders among the Japanese population \[[@B27-genes-10-00988]\]. In comparison to the finding done among Caucasians in Italy, a allele is a minor allele among Caucasians in Italy and the presence of either AA or AG genotypes is the protective factor for depression (OR = 0.67, 95% CI = 0.45--0.99) \[[@B28-genes-10-00988]\].

The findings of this study are of potential clinical and scientific importance as the identification of a significant association between particular candidate genes polymorphism with depression and stress among GDM women in Malaysia have certainly helped in the understanding of genetic aetiology among GDM women in local settings. Future studies should be conducted to validate the value of these candidate genes polymorphism in terms of genetic screening, so that the clinicians can send those GDM women at risk of having depression and stress for a genetic study.

Study Strength and Limitations
------------------------------

The present study contains multiple logistic regression analysis, adjusted for all socio-demographic backgrounds, and maternal and clinical profiles that potentially modulate the presentation of psychological symptoms. Therefore, the results shown on significant genotype related to depression and stress symptoms are clinically relevant despite this is an unmatched comparative case-control study, a sub-analysis from a cross-sectional study. The study demonstrates an association between candidate genes and the presence of depression, anxiety, or stress symptoms among GDM women. The interpretation of these association is limited by the screening nature of the psychometric tools used in measuring for these psychological symptoms, and not the diagnoses per se. Thus, the results should be interpreted cautiously. Future studies should be conducted with the inclusion of more SNP numbers per candidate gene to confirm the epigenetics-environmental moderator effects.

5. Conclusions {#sec5-genes-10-00988}
==============

A significant association was observed between SNP (rs17466684) of *EPHX2* and depression symptoms when adjusted for ethnicity, religion, the practice of home glucose monitoring, planned pregnancy, marital status, past obstetric history of abortion, underlying with allergy, a family history of depression, and anxiety with GDM. SNPs in *EPHX2* (rs17466684), *OXTR* (rs53576) and *NRG1* (rs2919375) are also associated with stress symptoms adjusted for ethnicity, religion, marital status, treatment regimens, past obstetric history of GDM, underlying with allergy and asthma and a family history of depression and anxiety.
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###### 

Candidate Genes and Single Nucleotide Polymorphism (SNP) Details.

  Candidate Genes                                                      SNP          Chromosome: Location   Sequence of SNP (60 upstream, 60 downstream)
  -------------------------------------------------------------------- ------------ ---------------------- -------------------------------------------------------------------
  Epoxide Hydrolase 2                                                  rs17466684   8:27595330             CCGTGGAGAC CCAAGTCCTC TTTGCATTGT CTCTAGAACT ACTGGATACT TCCTGGGTTT
  A/G                                                                                                      
  CCACTATCCT ATTTTCTAGT GGGGCCCTGT GATCCCCAGA GACAGACCCG TGTTCATTCT                                        
  Neuropeptide Y                                                       rs12501691   4:163346876            GTAAATATAT CTTACAGTTT TAGTTGCATG TTGCTTGTGT GATAGCCTTT ATCAATGAAG
  A/T                                                                                                      
  TATCCAAATT TAAAGTGCTA AACTATCTTT ATTGTCTGTC TAGGTATCTC CTCCTCATTG                                        
  Anoctamin 2                                                          rs12579350   12:5687935             AACAACACCA GGAGGTCAGG TCCAATGTCC CACACTGGTT CCCTCTCCTG ACTTTGCCTT
  A/G                                                                                                      
  ACCTTGTGTT GAGATTTAAA AGCATTAAAG AAAGGTATAT ATTATAAGGA CTGCTGAATT                                        
  Neuregulin 1                                                         rs2919375    8:32719327             AAACAAAACT GATAACGGCT GAAGTGGGTG ATGGCTACAT GGAGATTCAT TACACAATCC
  C/T                                                                                                      
  TTGTATTTTC AGGTTTTTAA TATGCATGTT TAAATGGATA TTATATATGT ACTTGTTTAA                                        
  FK506 binding protein 5                                              rs3800373    6: 35574699            CATGCAAAAA AATTTTGACT TTTTAGTACT AAGCTTAATT TTTAAAAACA AAATCTGTAG
  G/T                                                                                                      
  GTTGACAAAT AAATAGTTGC TCTTCTACAC TAGGGGTTTC ACCTGCAGGT TTGACACGCA                                        
  retinoid-related orphan receptor alpha                               rs4775340    15:60975553            AAACAGTAAG AAAATTGGAT CCTAGAACTC ACTCTGGAGA ACACTGAAAT GAACATGTGG
  A/G                                                                                                      
  GTCCTATTCA GAACATGTTT GCCTTGAGTG TATGGAATCT GGGTCACCTT CACTGAAAGC                                        
  oxytocin receptor genes                                              rs53576      3:8762685              TCCCCCACAC CTCGGGCACA GCATTCATGG AAAGGAAAGG TGTACGGGAC ATGCCCGAGG
  A/G                                                                                                      
  TCCTCAGTCC CACAGAAACA GGGAGGGGCT GGGAAGCTCA TTCTACAGAT GGGGAAACAG                                        
  Brain-derived neurotrophic factor                                    rs6265       11:27658369            GTGAATGGGC CCAAGGCAGG TTCAAGAGGC TTGACATCAT TGGCTGACAC TTTCGAACAC
  A/G                                                                                                      
  TGATAGAAGA GCTGTTGGAT GAGGACCAGA AAGTTCGGCC CAATGAAGAA AACAATAAGG                                        
  FK506 binding protein 5                                              rs9470080    6: 35678658            ATTGACAAAA AGCAGCTAAA GACAAAAACA GTTTCATAAT TACCATTTGT CCAAAGTCAA
  C/T                                                                                                      
  CTCTGAGCTA AAACACAATG TTTTTTATGT TTCTCTACTT ATAACAAAAT TTCGGGAAAA                                        
  Tryptophan hydroxylase 2                                             rs1843809    12:71954918            TAGTTATTTC AATCCATCTT ATTCTCTTGG AAAGAGGCCC TGAGCTCCTA CTTTAATTAT
  G/T                                                                                                      
  CCACTCTTGT TTGCTTAAAT TGATTTTGAA TATTATTGTG ATTGTGTTTT ATTATGAATG                                        
  Catenin Alpha 3                                                      rs10997242   10:66576537            CCCACCACCC TCCCCAATGA AGCAGTCTCC AGAGTCTTTG TTCCTATCTT TGTGTCCATT
  C/T                                                                                                      
  ATATTCAATG TTGAGCTTCC AATTATAAGC GAAAACATGT GGAATGTGGT TGTCTGTTCC                                        
  Phospholysine Phosphohistidine Inorganic Pyrophosphate Phosphatase   rs35936514   10:124556401           CACCGTGCAT TCTCCGGGGC CATCGTTTTA ATGGCTGCAC CCTGCTCCCG CGTGTGGACG
  C/T                                                                                                      
  ATCCTAAACA GTCCCTTAGT ATTATGGTTA GATGCTCCAT GTGTTTCCAA TTCTTCATTA                                        
  Calcium Voltage-Gated Channel Subunit Alpha1 C                       rs1006737    12:2236129             ACTTGGCTC TATCAAAGTC TTGCTATCAA TTACATAAGT TCCATTCCAT CTCAGCCCGAA
  A/G                                                                                                      
  TGTTTTCAGA GCCGGAGACC TCACAGTGTC TCTCAGGACA GTACCTTTCA GGTTTGAATG                                        
  Apolipoprotein L3                                                    rs132617     22:36137737            AGCAGATAAG GAGAGTTCTT TTTGTTTGTA TGAGAAGAAG AGTGTGTGTG CAGTAGCAAG
  C/T                                                                                                      
  GATTGACTGT ATACAATGAG CACAAATTCA GGTGGCTGTT TGGCCAGAGG CTTCCCATTA                                        
  Testis Expressed 51                                                  rs6733840    2:126902405            GTGTGATGCT TTGGCCAGGC TGGTGTGCTC CGACCCAGGA ACCTGCCCAC CTCATATTTA
  C/T                                                                                                      
  TGTCCAGTAT TTGGCCATGC CATGGGTGCA GATCCAAAGC CCTCACTCCC CTTTTCTCCT                                        
  Pleckstrin Homology And RhoGEF Domain Containing G1                  rs9372078    6:150592825            AAGCAGCTGG GGTGGACTTA CAGGAACTGG ACACAAGTCC CTGATTTGGA GTGTTTGCCA
  A/T                                                                                                      
  TTTTTGTGGT GTAAATATCT CCACCATGGC TGATTTCAAG CCACCAATGT GATGTCAGTT                                        
  5-Hydroxytrytamine receptor 2                                        rs6318       X: 114731326           GATTGTTTTT TTTTTTCTTA ATTTTCAGTG TGCACCTAAT TGGCCTATTG GTTTGGCAAT
  C/G                                                                                                      
  TGATATTTCT GTGAGCCCAG TAGCAGCTAT AGTAACTGAC ATTTTCAATA CCTCCGATGG                                        
  Sidekick Cell Adhesion Molecule 2                                    rs3816995    17:73339121            ACTGTGGGCC TCCCAGCCCC CTCACTGCCA AGGGGGTCTG GTGCCCGTTT GTGCCCGCCT
  A/G                                                                                                      
  CTGCTTCCTT CACAGCAGAT CCGGAACCGG AAGGATCTAC TATGGGGTTG GCCCAGAGCT                                        

genes-10-00988-t0A2_Table A2

###### 

Genotype and allelic information for candidate genes and its chi-squared goodness-of-fit based global distribution (n = 343).

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Candidate Genes   SNP          Genotype   Expected Genotype Frequency   Expected N   Frequency   N     Allele   Frequency   Call Rate, %   *p*-Value\
                                                                                                                                             Chi-Squared Goodness-of-Fit
  ----------------- ------------ ---------- ----------------------------- ------------ ----------- ----- -------- ----------- -------------- -----------------------------
  *BDNF*            rs6265       GG         0.466                         160          0.334       114   G\       0.576\      98.9           0.69
                                                                                                         A        0.424                      

  GA                0.333        114        0.484                         165                                                                

  AA                0.201        69         0.182                         62                                                                 

  *OXTR*            rs53576      AA         0.389                         134          0.269       92    A\       0.515\      98.9           0.68
                                                                                                         G        0.485                      

  AG                0.333        114        0.491                         168                                                                

  GG                0.278        95         0.240                         82                                                                 

  *RORA*            rs4775340    GG         0.450                         155          0.635       217   G\       0.800\      99.2           0.43
                                                                                                         A        0.200                      

  GA                0.333        114        0.330                         113                                                                

  AA                0.217        74         0.035                         12                                                                 

  *NRG1*            rs2919375    TT         0.388                         133          0.401       137   T\       0.634\      99.2           0.86
                                                                                                         C        0.366                      

  TC                0.333        114        0.465                         159                                                                

  CC                0.279        96         0.135                         46                                                                 

  *TPH2*            rs1843809    TT         0.514                         177          0.915       312   T\       0.958\      99.2           0.43
                                                                                                         G        0.042                      

  GT                0.333        114        0.085                         29                                                                 

  GG                0.153        52         0.000                         0                                                                  

  *LHPP*            rs35936514   CC         0.593                         204          0.474       162   C\       0.683\      99.2           0.45
                                                                                                         T        0.317                      

  CT                0.333        114        0.418                         143                                                                

  TT                0.074        25         0.108                         37                                                                 

  *FBKP5*           rs9470080    CC         0.363                         125          0.436       150   C\       0.662\      100            0.73
                                                                                                         T        0.338                      

  CT                0.333        114        0.451                         155                                                                

  TT                0.304        104        0.113                         39                                                                 

  *FBKP5*           rs3800373    TT         0.425                         146          0.429       145   T\       0.669\      98.4           0.17
                                                                                                         G        0.331                      

  TG                0.333        114        0.479                         162                                                                

  GG                0.242        83         0.092                         31                                                                 

  *TEX51*           rs6733840    TT         0.488                         168          0.638       219   C\       0.796\      99.7           0.68
                                                                                                         T        0.204                      

  TC                0.333        114        0.315                         108                                                                

  CC                0.178        61         0.047                         16                                                                 

  *PLEKHGI*         rs9372078    AA         0.384                         131          0.388       132   A\       0.624\      98.4           0.78
                                                                                                         T        0.376                      

  AT                0.333        114        0.471                         160                                                                

  TT                0.283        97         0.141                         48                                                                 

  *HTR2C*           rs6318       GG         0.571                         196          0.944       323   G\       0.971\      99.5           0.63
                                                                                                         C        0.029                      

  GC                0.333        114        0.053                         18                                                                 

  CC                0.095        33         0.003                         1                                                                  

  *EPHX2*           rs17466684   GG         0.536                         184          0.755       259   G\       0.864\      99.7           0.19
                                                                                                         A        0.136                      

  GA                0.333        114        0.219                         75                                                                 

  AA                0.131        45         0.026                         9                                                                  

  *ANO2*            rs12579350   GG         0.541                         186          0.860       297   G\       0.923\      100.0          0.28
                                                                                                         A        0.077                      

  GA                0.333        114        0.125                         43                                                                 

  AA                0.126        43         0.009                         3                                                                  

  *NPY5R*           rs12501691   TT         0.613                         210          0.682       234   T\       0.831\      99.5           0.18
                                                                                                         A        0.169                      

  TA                0.333        114        0.297                         102                                                                

  AA                0.054        19         0.020                         7                                                                  

  *SDK2*            rs3816995    GG         0.406                         140          0.617       211   G\       0.779\      99.2           0.39
                                                                                                         A        0.221                      

  GA                0.333        114        0.325                         111                                                                

  AA                0.260        89         0.058                         20                                                                 
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------

genes-10-00988-t0A3_Table A3

###### 

Analyses of the genotype of LHPP, SDK2, HTR2C, TEX51, PLEKHG1 and TPH2 among women with GDM were stratified by presence of psychological symptoms. \* *p*-value based on fisher's exact test.

  Candidate Genes   SNP          Genotype    Normal       Presence of Depression Symptoms   *p*-Value    Normal       Presence of Anxiety Symptoms   *p*-Value   Normal       Presence of Stress Symptoms   *p*-Value
  ----------------- ------------ ----------- ------------ --------------------------------- ------------ ------------ ------------------------------ ----------- ------------ ----------------------------- -----------
  *LHPP*            rs35936514   CC          139 (85.8)   23 (14.2)                         0.600        97 (59.9)    65 (40.1)                      0.262       144 (88.9)   18 (11.1)                     0.909
  CT                123 (86.0)   20 (14.0)   75 (52.4)    68 (47.6)                         125 (87.4)   18 (12.6)                                                                                          
  TT                34 (91.9)    3 (8.1)     24 (64.9)    13 (35.1)                         33 (89.2)    4 (10.8)                                                                                           
  CC genotype       139 (85.8)   23 (14.2)   0.701        97 (59.9)                         65 (40.1)    0.363        144 (88.9)                     18 (11.1)   0.750                                      
  T carrier         157 (87.2)   23 (12.8)   99 (55.0)    81 (45.0)                         158 (87.8)   22 (12.2)                                                                                          
  C carrier         262 (85.9)   43 (14.1)   0.445 \*     172(56.4)                         133 (43.6)   0.325        269 (88.2)                     36 (11.8)   1.000 \*                                   
  TT genotype       34 (91.9)    3 (8.1)     24 (65.9)    13 (35.1)                         33 (89.2)    4 (10.8)                                                                                           
  *SDK2*            rs3816995    GG          183 (86.7)   28 (13.3)                         0.910        119 (56.4)   92 (43.6)                      0.735       187 (88.6)   24 (11.4)                     0.920
  GA                96 (86.5)    15 (13.5)   65 (58.6)    46 (41.4)                         97 (87.4)    14 (12.6)                                                                                          
  AA                18 (90.0)    2 (10.0)    13 (65.0)    7 (35.0)                          18 (90.0)    2 (10.0)                                                                                           
  GG genotype       183 (86.7)   28 (13.3)   0.938        119 (56.4)                        92 (43.6)    0.567        187 (88.6)                     24 (11.4)   0.814                                      
  A carrier         114 (87.0)   17 (13.0)   78 (59.5)    53 (40.5)                         115 (87.8)   16 (12.2)                                                                                          
  G carrier         279 (86.6)   43 (13.4)   1.000 \*     184 (57.1)                        138 (42.9)   0.490        284 (88.2)                     38 (11.8)   1.000 \*                                   
  AA genotype       18 (90.0)    2 (10.0)    13 (65.0)    7 (35.0)                          18 (90.0)    2 (10.0)                                                                                           
  *HTR2C*           rs6318       GG          279 (86.4)   44 (13.6)                         0.883        187 (57.9)   136 (42.1)                     0.496 \*    286 (88.5)   37 (11.5)                     0.748
  GC                16 (88.9)    2 (11.1)    10 (55.6)    8 (44.4)                          15 (83.3)    3 (16.7)                                                                                           
  CC                1 (100.0)    0 (0.0)     0 (0.0)      1 (100.0)                         1 (100.0)    0 (0.0)                                                                                            
  GG genotype       279 (86.4)   44 (13.6)   1.000 \*     187 (57.9)                        136 (42.1)   0.652        286 (88.5)                     37 (11.5)   0.475 \*                                   
  C carrier         17 (89.5)    2 (10.5)    10 (52.6)    9 (47.4)                          16 (84.2)    3 (15.8)                                                                                           
  G carrier         295 (86.5)   46 (13.5)   1.000 \*     197 (57.8)                        144 (42.2)   0.424 \*     301 (88.3)                     40 (11.7)   1.000 \*                                   
  CC genotype       1 (100.0)    0 (0.0)     0 (0.0)      1 (100.0)                         1(100.0)     0 (0.0)                                                                                            
  *TEX51*           rs6733840    TT          189 (86.3)   30 (13.7)                         0.977        125 (57.1)   94 (42.9)                      0.914       191 (87.2)   28 (12.8)                     0.643
  TC                94 (87.0)    14 (13.0)   62 (57.4)    46 (42.6)                         98 (90.7)    10 (9.3)                                                                                           
  CC                14 (87.5)    2 (12.5)    10 (62.5)    6 (37.5)                          14 (87.5)    2 (12.5)                                                                                           
  TT genotype       189 (86.3)   30 (13.7)   0.835        125 (57.1)                        94 (42.9)    0.859        191 (87.2)                     28 (12.8)   0.389                                      
  C carrier         108 (87.1)   16 (12.9)   72 (58.1)    52 (41.9)                         112 (90.3)   12 (9.7)                                                                                           
  T carrier         282 (86.5)   44 (13.5)   1.000 \*     187 (57.2)                        140 (42.8)   0.675        289 (88.4)                     38 (11.6)   1.000 \*                                   
  CC genotype       14 (87.5)    2 (12.5)    10 (62.5)    6 (37.5)                          14 (87.5)    2 (12.5)                                                                                           
  *PLEKHG1*         rs9372078    AA          115 (87.1)   17 (12.9)                         0.951        75 (56.8)    57 (43.2)                      0.878       118 (89.4)   14 (10.6)                     0.763
  AT                138 (86.3)   22 (13.8)   95 (59.4)    65 (40.6)                         139 (86.9)   21 (13.1)                                                                                          
  TT                41 (85.4)    7 (14.6)    27 (56.3)    21 (43.8)                         43 (89.6)    5 (10.4)                                                                                           
  AA genotype       115 (87.1)   17 (12.9)   0.780        75 (56.8)                         57 (43.2)    0.738        118 (89.4)                     14 (10.6)   0.597                                      
  T carrier         179 (86.1)   29 (13.9)                122 (58.7)                        86 (41.3)    182 (87.5)   26 (12.5)                                                                             
  A carrier         253 (86.6)   39 (13.4)   0.818        170 (58.2)                        122 (41.8)   0.798        257 (88.0)                     35 (12.0)   0.754                                      
  TT genotype       41 (85.4)    7 (14.6)    27 (56.3)    21 (43.8)                         43 (89.6)    5 (10.4)                                                                                           
  *TPH2*            rs1843809    TT          269 (86.2)   43 (13.8)                         0.398 \*     179(57.4)    133 (42.6)                     0.896       274 (87.8)   38 (12.2)                     0.553 \*
  TG                27 (93.1)    2 (6.9)     17 (58.6)    12 (41.4)                         27 (93.1)    2 (6.9)                                                                                            
  GG                0 (0.0)      0 (0.0)     0 (0.0)      0 (0.0)                           0 (0.0)      0 (0.0)                                                                                            
  TT genotype       \-           \-          \-           \-                                \-           \-                                                                                                 
  G carrier         \-           \-          \-           \-                                \-           \-                                                                                                 
  T carrier         \-           \-          \-           \-                                \-           \-                                                                                                 
  GG genotype       \-           \-          \-           \-                                \-           \-                                                                                                 

genes-10-00988-t001_Table 1

###### 

Univariate analysis on the socio-demographic background and clinical characteristics of the participants with stratification by presence of psychological symptoms (n = 343).

  Parameters                                      Depression                     Anxiety             Stress                                                                                                                
  ----------------------------------------------- ------------------------------ ------------------- ------------ ------------------- ------------------- ------------ ------------------- ------------------- ----------- -----------
  ***Treatment Profile***                                                                                                                                                                                                  
  Treatments                                      OAD and/or diet modification   212(87.6)           30(12.4)     0.393               142 (58.7)          100 (41.3)   0.471               217 (89.7)          25 (10.3)   0.234 ^a^
  Insulin with/out OAD and/or diet modification   85(84.2)                       16(15.8)            55 (54.5)    46 (45.5)           86 (85.1)           15 (14.9)                                                        
  Self-Monitoring with Glucometer                 No                             46 (80.7)           11(19.3)     0.041 ^a^           33 (57.9)           24 (42.1)    0.841               50 (87.7)           7 (12.3)    0.624
  Yes                                             198 (90.4)                     21 (9.6)            130 (59.4)   89 (40.6)           197 (90.0)          22 (10.0)                                                        
  ***Socio-Demographic Factors***                                                                                                                                                                                          
  Age                                             32.17 ± 5.08                   31.80 ± 4.65        0.645        32.39 ± 5.04        31.73 ± 4.97        0.259        32.20 ± 5.00        31.53 ± 5.13        0.424       
  Ethnicity                                       Malay                          247 (89.5)          29 (10.5)    0.001 ^a^           167 (60.5)          109 (39.5)   0.019 ^a^           248 (89.9)          28 (10.1)   0.076 ^a^
  Non-Malay                                       50 (74.6)                      17 (25.4)           30 (44.8)    37 (55.2)           55 (82.1)           12 (17.9)                                                        
  BMI, kg/m^2^                                    29.23 ± 6.30                   29.12 ± 5.84        0.912        28.98 ± 5.57        29.53 ± 7.00        0.439        29.16 ± 5.96        29.59 ± 7.98        0.695       
  Religion                                        Muslim                         252 (89.7)          29 (10.3)    0.000 ^a^           169 (60.1)          112 (39.9)   0.031 ^a^           253 (90.0)          28 (10.0)   0.037 ^a^
  Non-Muslim                                      45 (72.6)                      17 (27.4)           28 (45.2)    34 (54.8)           50 (80.6)           12 (19.4)                                                        
  Education                                       Secondary and below            151 (84.8)          27 (15.2)    0.321               102 (57.3)          76 (42.7)    0.959               155 (87.1)          23 (12.9)   0.450
  Tertiary                                        146 (88.5)                     19 (11.5)           95 (57.6)    70 (42.4)           148 (89.7)          17 (10.3)                                                        
  Employment                                      Unemployed                     115 (85.8)          19 (14.2)    0.738               79 (59.0)           55 (41.0)    0.648               116 (86.6)          18 (13.4)   0.413
  Employed                                        182 (87.1)                     27 (12.9)           118 (56.5)   91 (43.5)           187 (89.5)          22 (10.5)                                                        
  Family Income, Ringgit Malaysia                 3714.90 ± 2400.77              3763.41 ± 3427.06   0.910        3638.01 ± 2490.53   3829.04 ± 2635.63   0.513        3690.32 ± 2397.41   3951.35 ± 3531.63   0.665       
  Pregnancy Planned                               No                             212 (88.7)          27 (11.3)    0.082 ^a^           142 (59.4)          97 (40.6)    0.261               214 (89.5)          25 (10.5)   0.293
  Yes                                             85 (81.7)                      19 (18.3)           55 (52.9)    49 (47.1)           89 (85.6)           15 (14.4)                                                        
  Marital Status                                  Without husband                9 (64.3)            5 (35.7)     0.027 ^b^           8 (57.1)            6 (42.9)     0.982               10 (71.4)           4 (28.6)    0.067 ^b^
  With husband                                    288 (87.5)                     41 (12.5)           189 (57.4)   140 (42.6)          450(90.0)           50(10.0)                                                         
  Parity                                          Nulliparous-Primiparous        161 (85.6)          27 (14.4)    0.569               100 (53.2)          88 (46.8)    0.080 ^a^           165 (87.8)          23 (12.2)   0.716
  Multiparous ≥ 2                                 136 (87.7)                     19 (12.3)           97 (62.6)    58 (37.4)           138 (89.0)          17 (11.0)                                                        
  Smoking habit                                   No                             291 (86.4)          46 (13.6)    1.000               191 (56.7)          146 (43.3)   0.040 ^b^           297 (88.1)          40 (11.9)   1.000
  Yes                                             6 (100.0)                      0 (0.0)             6 (100.0)    0(0.0)              6 (100.0)           0 (0.0)                                                          
  Drink alcohol                                   No                             291 (86.6)          45 (13.4)    1.000               193 (57.4)          143 (42.6)   1.000               297 (88.4)          39 (11.6)   0.584
  Yes                                             6 (85.7)                       1 (13.3)            4 (57.1)     3 (42.9)            6 (85.7)            1 (14.3)                                                         
  ***Past Obstetric History***                                                                                                                                                                                             
  Abortion                                        No                             225 (88.2)          30 (11.8)    0.128 ^a^           150 (58.8)          105 (41.2)   0.376               226 (88.6)          29 (11.4)   0.776
  Yes                                             72 (81.8)                      16 (18.2)           47 (53.4)    41 (46.6)           77 (87.5)           11 (12.5)                                                        
  Macrosomia                                      No                             290 (86.3)          46 (13.7)    0.600               192 (57.1)          144 (42.9)   0.703               296 (88.1)          40 (11.9)   1.000
  Yes                                             7 (100.0)                      0 (0.0)             5 (71.4)     2 (28.6)            7 (100.0)           0 (0.0)                                                          
  Gestational hypertension                        No                             283 (86.5)          44 (13.5)    1.000               188 (57.5)          139 (42.5)   0.922               289 (88.4)          38 (11.6)   1.000
  Yes                                             14 (87.5)                      2 (12.5)            9 (56.3)     7 (43.8)            14 (87.5)           2 (12.5)                                                         
  Stillbirth                                      No                             284 (86.6)          44 (13.4)    1.000               187 (57.0)          141 (43.0)   0.460               289 (88.1)          39 (11.9)   1.000
  Yes                                             13 (86.7)                      2 (13.3)            10 (66.7)    5 (33.3)            14 (93.3)           1 (6.7)                                                          
  Preterm Delivery                                No                             284 (86.6)          44 (13.4)    1.000               190 (57.9)          138 (42.1)   0.388               289 (88.1)          39 (11.9)   1.000
  Yes                                             13 (86.7)                      2 (13.3)            7 (46.7)     8 (53.3)            14 (93.3)           1 (6.7)                                                          
  Gestational Diabetes Mellitus                   No                             230 (87.1)          34 (12.9)    0.597               153 (58.0)          111 (42.0)   0.722               239 (90.5)          25 (9.5)    0.021 ^a^
  Yes                                             67 (84.8)                      12 (15.2)           44 (55.7)    35 (44.3)           64 (81.0)           15 (19.0)                                                        
  ***Current Medical Problems***                                                                                                                                                                                           
  Hypertension                                    No                             284 (86.6)          44 (13.4)    1.000               188 (57.3)          140 (42.7)   0.837               291 (88.7)          37 (11.3)   0.398
  Yes                                             13 (86.7)                      2 (13.3             9 (60.0)     6 (40.0)            12 (80.0)           3 (20.0)                                                         
  Allergy                                         No                             294 (87.5)          42 (12.5)    0.007 ^b^           195 (58.0)          141 (42.0)   0.141 ^b^           300 (89.3)          36 (10.7)   0.004 ^b^
  Yes                                             3 (42.9)                       4 (57.1)            2 (28.6)     5 (71.4)            3 (42.9)            4 (57.1)                                                         
  Asthma                                          No                             273 (86.9)          41 (13.1)    0.567               186 (59.2)          128 (40.8)   0.026 ^a^           280 (89.2)          34 (10.8)   0.128 ^b^
  Yes                                             24 (82.8)                      5 (17.2)            11 (37.9)    18 (62.1)           23 (79.3)           6 (20.7)                                                         
  Heart disease                                   No                             291 (86.4)          46 (13.6)    1.000               192 (57.0)          145 (43.0)   0.246 ^b^           297 (88.1)          40 (11.9)   1.000
  Yes                                             6 (100.0)                      0 (0.0)             5 (83.3)     1 (16.7)            6 (100.0)           0 (0.0)                                                          
  Anaemia                                         No                             278 (86.6)          43 (13.4)    1.000               183 (57.0)          138 (43.0)   0.543               282 (87.9)          39 (12.1)   0.491
  Yes                                             19 (86.4)                      3 (13.6)            14 (63.6)    8 (36.4)            21 (95.5)           1 (4.5)                                                          
  Thalassemia                                     No                             294 (86.5)          46 (13.5)    1.000               196 (57.6)          144 (42.4)   0.577               300 (88.2)          40 (11.8)   1.000
  Yes                                             3 (100.0)                      0 (0.0)             1 (33.3)     2 (66.7)            3 (100.0)           0 (0.0)                                                          
  ***Family History***                                                                                                                                                                                                     
  Diabetes mellitus                               No                             133 (88.1)          18 (11.9)    0.473               88 (58.3)           63 (41.7)    0.779               136 (90.1)          15 (9.9)    0.377
  Yes                                             164 (85.4)                     28 (14.6)           109 (56.8)   83 (43.2)           167 (87.0)          25 (13.0)                                                        
  Heart Disease                                   No                             250 (86.5)          39 (13.5)    0.916               170 (58.8)          119 (41.2)   0.229 ^a^           255 (88.2)          34 (11.8)   0.891
  Yes                                             47 (87.0)                      7 (13.0)            27 (50.0)    27 (50.0)           48 (88.9)           6 (11.1)                                                         
  Hypertension                                    No                             138 (85.7)          23 (14.3)    0.655               88 (54.7)           73 (45.3)    0.328               142 (88.2)          19 (11.8)   0.940
  Yes                                             159 (87.4)                     23 (12.6)           109 (59.9)   73 (40.1)           161 (88.5)          21 (11.5)                                                        
  Depression and Anxiety                          No                             290 (87.6)          41 (12.4)    0.013 ^b^           193 (58.3)          138 (41.7)   0.086 ^a^           294 (88.8)          37 (11.2)   0.153 ^b^
  Yes                                             7 (58.3)                       5 (41.7)            4 (33.3)     8 (66.7)            9 (75.0)            3 (25.0)                                                         
  Gestational Diabetes Mellitus                   No                             194 (88.6)          25 (11.4)    0.149 ^a^           128 (58.4)          91 (41.6)    0.614               196 (89.5)          23 (10.5)   0.374
  Yes                                             103 (83.1)                     21 (16.9)           69 (55.6)    55 (42.6)           107 (86.3)          17 (13.7)                                                        

Data are presented as either n (%) or mean ± SD. ^a^ Pearson Chi-Square at *p* \< 0.25 entered multivariate logistic regression; ^b^ Fisher's Exact Test at *p* \< 0.25 entered multivariate logistic regression.

genes-10-00988-t002_Table 2

###### 

Analyses of the *EPHX2, NPY5R, ANO2, NRG1, FKBP5, RORA, OXTR* and *BDNF* genotype among women with GDM were stratified by psychological symptoms.

  Candidate Genes   SNP          Genotype     Normal       Presence of Depression Symptoms   *p*-Value    Normal       Presence of Anxiety Symptoms   *p*-Value    Normal       Presence of Stress Symptoms   *p*-Value
  ----------------- ------------ ------------ ------------ --------------------------------- ------------ ------------ ------------------------------ ------------ ------------ ----------------------------- -----------
  EPHX2             rs17466684   GG           223 (75.1)   36 (78.3)                         0.122        155 (78.7)   104 (71.2)                     0.267        228 (75.2)   31 (77.5)                     0.078
  GA                68(22.9)     7 (15.2)     38(19.3)     37 (25.3)                         69 (22.8)    6 (15.0)                                                                                            
  AA                6 (2.0)      3 (6.5)      4 (2.0)      5 (3.5)                           6 (2.0)      3 (7.5)                                                                                             
  GG genotype       223 (75.1)   36 (78.3)    0.641        155 (78.7)                        104 (71.2)   0.113        228 (75.2)                     31 (77.5)    0.756                                      
  A carrier         74 (24.9)    10 (21.7)    42 (21.3)    42 (28.8)                         75 (24.8)    9 (22.5)                                                                                            
  G carrier         291 (98.0)   43 (93.5)    0.106 \*     193 (98.0)                        141 (96.6)   0.504 \*     297 (98.0)                     37 (92.5)    0.075 \*                                   
  AA genotype       6 (2.0)      3 (6.5)      4 (2.0)      5 (3.4)                           6 (2.0)      3 (7.5)                                                                                             
  NPY5R             rs12501691   TT           202 (68.0)   32 (69.5)                         0.972        137 (69.6)   97 (66.4)                      0.550        202 (66.7)   32 (80.0)                     0.197
  TA                89 (30.0)    13 (28.3)    55 (27.9)    47 (32.2)                         95 (31.3)    7 (17.5)                                                                                            
  AA                6 (2.0)      1 (2.2)      5 (2.5)      2 (1.4)                           6 (2.0)      1 (2.5)                                                                                             
  TT genotype       202 (68.0)   32 (69.6)    0.833        137 (69.5)                        97 (66.4)    0.541        202 (66.7)                     32 (80.0)    0.089                                      
  A carrier         95 (32.0)    14 (30.4)    60 (30.5)    49 (33.6)                         101 (33.3)   8 (20.0)                                                                                            
  T carrier         291 (98.0)   45 (97.8)    1.000        192 (97.5)                        144 (98.6)   0.703 \*     297 (98.0)                     39 (97.5)    0.584                                      
  AA genotype       6 (2.0)      1 (2.2)      5 (2.5)      2 (1.4)                           6 (2.0)      1 (2.5)                                                                                             
  ANO2              rs12579350   GG           261 (87.9)   36(78.3)                          0.107        168 (85.3)   129 (88.3)                     0.704        263 (86.8)   34 (85.0)                     0.730
  GA                33 (11.1)    10 (21.7)    27 (13.7)    16 (11.0)                         37 (12.2)    6 (15.0)                                                                                            
  AA                3 (1.0)      0 (0.0)      2 (1.0)      1 (0.7)                           3 (1.0)      0 (0.0)                                                                                             
  GG genotype       261 (87.9)   36 (78.3)    0.075        168 (85.3)                        129 (88.4)   0.408        263 (86.8)                     34 (85.0)    0.754                                      
  A carrier         36 (12.1)    10 (21.7)    29 (14.7)    17 (11.6)                         40 (13.2)    6 (15.0)                                                                                            
  G carrier         294 (99.0)   46 (100.0)   1.000        195 (99.0)                        145 (99.3)   1.000 \*     300 (99.0)                     40 (100.0)   1.000                                      
  AA genotype       3 (1.0)      0 (0.0)      2 (1.0)      1 (0.7)                           3 (1.0)      0 (0.0)                                                                                             
  NRG1              rs2919375    TT           119 (40.2)   18 (39.1)                         0.812        78 (39.8)    59 (40.4)                      0.981        119 (39.4)   18 (45.0)                     0.097
  TC                136 (45.9)   23 (50.0)    92 (46.9)    67 (45.9)                         138 (45.7)   21 (52.5)                                                                                           
  CC                41 (13.9)    5 (10.9)     26 (13.3)    20 (13.7)                         45 (14.9)    1 (2.5)                                                                                             
  TT genotype       119 (40.2)   18 (39.1)    1.000        78 (39.8)                         59 (40.4)    0.909        119 (39.4)                     18 (45.0)    0.497                                      
  C carrier         177 (59.8)   28 (60.9)    118 (60.2)   87 (59.6)                         183 (60.6)   22 (55.0)                                                                                           
  T carrier         255 (86.1)   41 (89.1)    0.581        170 (86.7)                        126 (86.3)   0.908        257 (85.1)                     39 (97.5)    0.031 \*                                   
  CC genotype       41 (13.9)    5 (10.9)     26 (13.3)    20 (13.7)                         45 (14.9)    1 (2.5)                                                                                             
  FKBP5             rs3800373    TT           122 (41.8)   23 (50.0)                         0.097        82 (42.5)    63 (43.4)                      0.982        122 (40.9)   23 (57.5)                     0.103
  TG                146 (50.0)   16 (34.8)    93 (48.2)    69 (47.6)                         149 (50.0)   13 (32.5)                                                                                           
  GG                24 (8.2)     7 (15.2)     18 (9.3)     13 (9.0)                          27 (9.1)     4 (10.0)                                                                                            
  TT genotype       122 (41.8)   23 (50.0)    0.295        82 (42.5)                         63 (43.4)    0.86         122 (40.9)                     23 (57.5)    0.047                                      
  G carrier         170 (58.2)   23 (50.0)    111 (57.5)   82 (56.6)                         176 (59.1)   17 (42.5)                                                                                           
  T carrier         268 (91.8)   39 (84.8)    0.164 \*     175 (90.7)                        132 (91.0)   0.909        271 (90.9)                     36 (90.0)    0.774                                      
  GG genotype       24 (8.2)     7 (15.2)     18 (9.3)     13 (9.0)                                       27 (9.1)     4 (10.0)                                                                               
  RORA              rs4775340    GG           186 (62.9)   31 (67.4)                         0.775        127 (64.5)   90 (62.1)                      0.818        188 (62.3)   29 (72.5)                     0.449
  GA                99 (33.4)    14 (30.4)    65 (32.5)    49 (33.8)                         103 (34.1)   10 (25.0)                                                                                           
  AA                11 (3.7)     1 (2.2)      6 (3.0)      6 (4.1)                           11 (3.6)     1 (2.5)                                                                                             
  GG genotype       186 (62.8)   31 (67.4)    0.551        127 (64.5)                        90 (62.1)    0.649        188 (62.3)                     29 (72.5)    0.206                                      
  A carrier         110 (37.2)   15 (32.6)    70 (35.5)    55 (37.9)                         114 (37.7)   11 (27.5)                                                                                           
  G carrier         285 (96.3)   45 (97.8)    1.000 \*     191 (97.0)                        139(95.9)    0.587        291 (96.4)                     39 (97.5)    1.000 \*                                   
  AA genotype       11 (3.7)     1 (2.2)      6 (3.0)      6 (4.1)                           11 (3.6)     1 (2.5)                                                                                             
  OXTR              rs53576      AA           76 (25.7)    16 (34.8)                         0.137        49(24.9)     43(29.7)                       0.611        81 (26.8)    11 (27.5)                     0.337
  AG                114 (48.6)   24 (52.2)    99 (50.3)    69 (47.6)                         145 (48.0)   23 (57.5)                                                                                           
  GG                76 (25.7)    6 (13.0)     49 (24.9)    33 (22.8)                         76 (25.2)    6 (15.0)                                                                                            
  AA genotype       76 (25.7)    16 (34.8)    0.195        49 (24.9)                         43 (29.7)    0.324        81 (26.8)                      11 (27.5)    1.000 \*                                   
  G carrier         220 (74.3)   30 (65.2)    148 (75.1)   102 (70.3)                        221 (73.2)   29 (72.5)                                                                                           
  A carrier         220 (74.3)   40 (87.0)    0.062        148 (75.1)                        112 (77.2)   0.651        226 (74.8)                     34 (85.0)    0.157                                      
  GG genotype       76 (25.7)    6 (13.0)     49 (24.9)    33 (22.8)                         76 (25.2)    6 (15.0)                                                                                            
  BDNF              rs6265       GG           95 (32.1)    19 (42.2)                         0.361        62 (31.4)    52 (36.1)                      0.646        96 (31.9)    18 (45.0)                     0.230
  GA                145 (49.0)   20 (44.4)    99 (50.3)    66 (45.8)                         148 (49.2)   17 (42.5)                                                                                           
  AA                56 (18.9)    6 (13.3)     36 (18.3)    26 (18.1)                         57 (18.9)    5 (12.5)                                                                                            
  GG genotype       95 (32.1)    19 (42.2)    0.180        62 (31.5)                         52 (36.1)    0.370        96 (31.9)                      18 (45.0)    0.099                                      
  A carrier         201 (67.9)   26 (57.8)    135 (68.5)   92 (63.9)                         205 (68.1)   22 (55.0)                                                                                           
  G carrier         240 (81.1)   39 (86.7)    0.365        161 (81.7)                        118 (81.9)   0.959        244 (81.1)                     35 (87.5)    0.321                                      
  AA genotype       56 (18.9)    6 (13.3)     36 (18.3)    26 (18.1)                         57 (18.9)    5 (12.5)                                                                                            
  FKBP5             rs9470080    CC           128 (43.0)   22 (47.8)                         0.681        85 (42.9)    65 (44.5)                      0.953        127 (41.8)   23 (57.5)                     0.160
  CT                137 (46.0)   18 (39.2)    90 (45.5)    65 (44.5)                         142 (46.7)   13 (32.5)                                                                                           
  TT                33 (11.0)    6 (13.0)     23 (11.6)    16 (11.0)                         35 (11.5)    4 (10.0)                                                                                            
  CC genotype       128 (43.0)   22 (47.8)    0.535        85 (42.9)                         65(44.5)     0.769        127 (41.8)                     23 (57.5)    0.059                                      
  T carrier         170 (57.0)   24 (52.2)    113 (57.1)   81 (55.5)                         177 (58.2)   17 (42.5)                                                                                           
  C carrier         265 (88.9)   40 (87.0)    0.695        175 (88.4)                        130 (89.0)   0.849        269 (88.5)                     36 (90.0)    1.000 \*                                   
  TT genotype       33 (11.1)    6 (13.0)     23 (11.6)    16 (11.0)                         35 (11.5)    4 (10.0)                                                                                            

Note: \* *p-*value based on fisher's exact test.

genes-10-00988-t003_Table 3

###### 

Multiple regression analysis between genotypes of candidate genes and the presence of psychological symptoms adjusted for the confounding factors (n = 343).

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Candidate Genes\    Geno-Types               Depression Symptoms      Geno-Types   Anxiety Symptoms        Geno-Types              Stress Symptoms                                                     
  SNP                                                                                                                                                                                                    
  ------------------- ------------------------ ------------------------ ------------ ----------------------- ----------------------- ----------------- ------------------------ ------------------------ -------
  *EPHX2*\            GG/GA                    1                        1            GG                      1                       1                 GG/GA                    1                        1
  *rs17466684*                                                                                                                                                                                           

  AA                  3.846\                   7.854\                   AA/AG        1.490\                  1.580\                  AA                4.622\                   7.664\                   
                      (0.852--17.353), 0.080   (1.330--46.360), 0.023                (0.909--2.444), 0.114   (0.943--2.659), 0.083                     (0.964--22.158), 0.056   (1.579--37.197), 0.012   

  *ANO2*\             GG                       1                        1            \-                      \-                      \-                \-                       \-                       \-
  *rs12579350*                                                                                                                                                                                           

  AA/AG               2.037\                   1.880\                   \-           \-                      \-                      \-                \-                       \-                       
                      (0.907--4.573), 0.085    (0.655--5.393), 0.240                                                                                                                                     

  *FKBP5*\            TT/TG                    1                        1            \-                      \-                      \-                GG/GT                    1                        1
  *rs3800373*                                                                                                                                                                                            

  GG                  1.879\                   2.497\                   \-           \-                      \-                      TT                1.446\                   1.963\                   
                      (0.729--4.841), 0.192    (0.746--8.359), 0.138                                                                                   (0.255--8.193), 0.677    (0.952--4.045), 0.068    

  *OXTR*\             GG                       1                        1            \-                      \-                      \-                GG                       1                        1
  *rs53576*                                                                                                                                                                                              

  AA/AG               2.490\                   2.114\                   \-           \-                      \-                      AA/AG             2.228\                   2.981\                   
                      (0.988--6.274), 0.053    (0.704--6.348), 0.182                                                                                   (0.8595--5.779), 0.099   (1.058--8.402), 0.039    

  *BDNF*\             AA/AG                    1                        1            \-                      \-                      \-                AA/AG                    1                        1
  *rs6265*                                                                                                                                                                                               

  GG                  1.498\                   1.045\                   \-           \-                      \-                      GG                1.883\                   1.651\                   
                      (0.778--2.885), 0.227    (0.429--2.548), 0.922                                                                                   (0.932--3.802), 0.078    (0.786--3.468), 0.185    

  *NPY5R*\            \-                       \-                       \-           \-                      \-                      \-                AA/AT                    1                        1.000
  *rs12501691*                                                                                                                                                                                           

  \-                  \-                       \-                       \-           \-                      \-                      TT                2.206\                   2.182\                   
                                                                                                                                                       (0.948--5.136),0.066     (0.915--5.204), 0.079    

  *NRG1*\             \-                       \-                       \-           \-                      \-                      \-                CC                       1                        1
  *rs2919375*                                                                                                                                                                                            

  \-                  \-                       \-                       \-           \-                      \-                      TT/TC             7.752\                   9.894\                   
                                                                                                                                                       (1.000--60.105), 0.050   (1.159--84.427), 0.036   

  *FKBP5 rs9470080*   \-                       \-                       \-           \-                      \-                      \-                TT/TC                    1                        1

  \-                  \-                       \-                       \-           \-                      \-                      CC                1.539\                   1.118\                   
                                                                                                                                                       (0.271--8.739), 0.627    (0.161--7.762), 0.910    

  *RORA*\             \-                       \-                       \-           \-                      \-                      \-                AA/AG                    1                        1
  *rs4775340*                                                                                                                                                                                            

  \-                  \-                       \-                       \-           \-                      \-                      GG                1.822\                   1.790\                   
                                                                                                                                                       (0.848--3.914), 0.124    (0.789--4.061), 0.164    
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Note: Adjusted OR was determined by adjusting for socio-demographical and clinical moderators with *p-*value \< 0.25 in univariate analysis.
